Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?
Metformin is the most commonly used glucose-lowering therapy (GLT) worldwide and remains the first-line therapy for newly diagnosed individuals with type 2 diabetes (T2D) in management algorithms and guidelines after the UK Prospective Diabetes Study (UKPDS) showed cardiovascular mortality benefits...
Saved in:
Main Authors: | Ehtasham Ahmad (Author), Jack A. Sargeant (Author), Francesco Zaccardi (Author), Kamlesh Khunti (Author), David R. Webb (Author), Melanie J. Davies (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metformin and Vitamin B12 Deficiency: Where Do We Stand?
by: Marwan Awad Ahmed
Published: (2016) -
Rethinking speaking in ELT: Where does intelligibility stand in the EFL classroom?
by: Rúben Constantino Correia
Published: (2024) -
Vitamin D in skin psoriasis and psoriatic arthritis: where does it stand?
by: Sarah El Tawab, et al.
Published: (2021) -
The rising trend of prostate cancer: where does Sri Lanka stand?
by: Thanuja A. Wickramatunga, et al.
Published: (2022) -
Reducing sedentary time in adults at risk of type 2 diabetes: process evaluation of the STAND (Sedentary Time ANd Diabetes) RCT
by: Stuart J. H. Biddle, et al.
Published: (2017)